Log in to save to my catalogue

De novo NAD.sup.+ biosynthetic impairment in acute kidney injury in humans

De novo NAD.sup.+ biosynthetic impairment in acute kidney injury in humans

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A572904647

De novo NAD.sup.+ biosynthetic impairment in acute kidney injury in humans

About this item

Full title

De novo NAD.sup.+ biosynthetic impairment in acute kidney injury in humans

Publisher

Nature Publishing Group

Journal title

Nature medicine, 2018-09, Vol.24 (9), p.1351

Language

English

Formats

Publication information

Publisher

Nature Publishing Group

More information

Scope and Contents

Contents

Nicotinamide adenine dinucleotide (NAD.sup.+) extends longevity in experimental organisms, raising interest in its impact on human health. De novo NAD.sup.+ biosynthesis from tryptophan is evolutionarily conserved yet considered supplanted among higher species by biosynthesis from nicotinamide (NAM). Here we show that a bottleneck enzyme in de novo...

Alternative Titles

Full title

De novo NAD.sup.+ biosynthetic impairment in acute kidney injury in humans

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A572904647

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A572904647

Other Identifiers

ISSN

1078-8956

DOI

10.1038/s41591-018-0138-z

How to access this item